Delivery Order SPE2DR25D3201-SPE2DR26FT4UJ
Award Date 12/17/25
Potential Completion Date 1/9/26
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Imbruvica 140 mg capsules (120-count) with a ceiling value of $11,405.25. This firm fixed-price delivery order is scheduled for completion by January 2, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $48,701.22 to AmerisourceBergen Drug Corp for supply of Imbruvica 140 mg capsules (quantity: 90 units) with a completion date of October 10, 2025. This competitive award, issued on September 19, 2025, carries firm fixed pricing and contains no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp for 28 tablets of Imbruvica 280 mg on November 17, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a ceiling value of $24,350.61. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, was competitively awarded without a set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $11,405.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (120-count units) on November 28, 2025. This is a firm fixed price, non-set-aside contract with a completion date of December 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,553.93 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a completion deadline of December 9, 2025. This firm fixed-price contract, awarded without set-aside designation, reflects a competitive procurement executed under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The award is issued to the contractor's corporate office located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Imbruvica 140 mg capsules (120-count units) with a ceiling value of $10,822.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by November 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on August 18, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,350.61 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units). This firm fixed-price delivery order, issued on July 22, 2025, will be completed by August 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-competitive set-aside award and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $16,233.74 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price, competitively awarded delivery order was placed without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under...